We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.
Notice for glofitamab (Roche Products Pty Limited)
Active ingredients
glofitamab
Sponsor
Date of review outcome
Lapse date
Type
Orphan drug
Indication
Treatment of diffuse large B-cell lymphoma
Therapeutic area
Haematology